Primary Record
Arg-gly-asp-ser
- In stock
- 5,160 g
- Purity
- 98.3 %
- CAS
- 91037-65-9
Compound Identifiers & Properties
- CAS
- 91037-65-9
- PubChem CID
- 107775
- SMILES
- C(C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N)CN=C(N)N
- Canonical SMILES
- NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O
Names & Synonyms
- Arg-gly-asp-ser
- Rgds peptide
- Fibronectin tetrapeptide
- 91037-65-9
- RGDS
- H-Arg-Gly-Asp-Ser-OH
- Arg Gly Asp Ser
- Arginyl-glycyl-aspartyl-serine
- AC6UDA2MFC
- Arg-Gly-Asp-Ser?
- Fibronectin Inhibitor
- UNII-AC6UDA2MFC
- Arg-Gly-Asp-Ser peptide
- RefChem:113929
- C15H27N7O8
- L-ARG-GLY-ASP-SER
- AC1Q5QP3
- CHEMBL265628
- orb363878
- MFCD00076452
- AC1L32Q9
- orb2815842
- SCHEMBL7394659
- SCHEMBL29350833
- KS-00000XPX
- L-Arginylglycyl-L-alpha-aspartyl-L-serine
- DTXSID50920002
- Fibronectin Inhibitor Tetrapeptide
- CHEBI:232857
- NNRFRJQMBSBXGO-CIUDSAMLSA-N
- l-arginylglycyl-l-|A-aspartyl-l-serine
- ZINC3927570
- 3450AH
- AR-1J3020
- BDBM50241180
- CID107775
- DU-728
- RGDS peptide;Fibronectin tetrapeptide
- L-Serine, L-arginylglycyl-L-alpha-aspartyl-
- AKOS024457642
- C15-H27-N7-O8
- RGDS peptide; Fibronectin tetrapeptide
- Arg-Gly-Asp-Ser, >=95% (HPLC)
- BAT-010205
- CS-3266
- FR73590
- NCGC00167153-01
- AS-56630
- DA-61200
- HY-12290
- J394.099C
- LS-178134
- ST24045982
- C77102
- A916494
- L-Serine, N-(N-(N-L-arginylglycyl)-L-alpha-aspartyl)-
- BRD-K08859203-001-01-9
- L-SERINE, L-ARGINYLGLYCYL-L-.ALPHA.-ASPARTYL-
- Q27273860
- (3S)-3-[[2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-4-oxobutanoic acid
- (3S)-3-{2-[(2S)-2-AMINO-5-CARBAMIMIDAMIDOPENTANAMIDO]ACETAMIDO}-3-{[(1S)-1-CARBOXY-2-HYDROXYETHYL]CARBAMOYL}PROPANOIC ACID
- (3S)-3-[(2-{[(2S)-2-Amino-5-(carbamimidoylamino)-1-hydroxypentylidene]amino}-1-hydroxyethylidene)amino]-4-{[(1S)-1-carboxy-2-hydroxyethyl]imino}-4-hydroxybutanoic acid
- (3S)-3-[[2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(2S)-1,3-dihydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
- (3S)-3-[[2-[[(2S)-2-amino-5-guanidino-pentanoyl]amino]acetyl]amino]-4-[[(1S)-1-carboxy-2-hydroxy-ethyl]amino]-4-oxo-butanoic acid
- (6S,12S,15S)-1,6-diamino-12-(carboxymethyl)-15-(hydroxymethyl)-1-imino-7,10,13-trioxo-2,8,11,14-tetraazahexadecan-16-oic acid
- (6S,12S,15S)-1,6-diamino-12-(carboxymethyl)-16-hydroxy-1-imino-7,10,13-trioxo-2,8,11,14-tetraazahexadecane-15-carboxylic acid
- (S)-3-[2-((S)-2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-((R)-1-carboxy-2-hydroxy-ethyl)-succinamic acid
- (S)-3-[2-((S)-2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-((S)-1-carboxy-2-hydroxy-ethyl)-succinamic acid
- 2-[1-[1-amino-4-amino(imino)methylamino-(1S)-butylcarboxamidomethylcarboxamido]-2-carboxy-(1S)-ethylcarboxamido]-3-hydroxy-(2S)-propanoic acid
- 2-{1-[1-amino-4-amino(imino)methylaminobutylcarboxamidomethylcarboxamido]-2-carboxyethylcarboxamido}-3-hydroxypropanoic acid
- 3-({2-[(2-Amino-5-carbamimidamido-1-hydroxypentylidene)amino]-1-hydroxyethylidene}amino)-4-[(1-carboxy-2-hydroxyethyl)imino]-4-hydroxybutanoic acid
- 3-[(S)-2-((S)-2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-(1-carboxy-2-hydroxy-ethyl)-succinamic acid
- 3-[2-((S)-2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-((S)-1-carboxy-2-hydroxy-ethyl)-succinamic acid
- 3-[2-(2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-(1-carboxy-2-hydroxy-ethyl)-succinamic acid
- 3-[2-(2-Amino-5-guanidino-pentanoylamino)-acetylamino]-N-(1-carboxy-2-hydroxy-ethyl)-succinamic acid (RGDS)
- 970-33-2